This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
Exploring AI Tools: Bridging Language and Technology for Language Experts
This ProZ/TV event is aimed at helping language professionals harness the power of AI tools to enhance your work and make informed business decisions for future success. In this event, we will delve into the world of AI-supported tools tailored specifically for language experts, providing practical insights and real-world examples.
Event access: this is a member-only event. If you are a ProZ.com paying member, register using the "Register for this event" button above and visit this page on the day and time of the event to attend (sessions will be broadcasted live). Not a member yet? Obtain unrestricted access to this event and to a full list of membership benefits by joining today. Check membership options »
Event recording: this event will be recorded and made available to ProZ.com Premium subscribers only (a few days after the event). If you are not a Premium subscriber, consider upgrading now. Check ProZ.com Premium »
This person has a SecurePRO™ card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePRO™ card you must be a ProZ.com Business member or Plus subscriber.
Affiliations
This person is not affiliated with any business or Blue Board record at ProZ.com.
Korean to English: Drug Manual General field: Medical Detailed field: Medical: Pharmaceuticals
Source text - Korean 이 약은 아래와 같은 성인 환자의 체중관리를 위해 칼로리 저감 식이요법 및 신체 활동 증대의 보조제로서 투여한다.
- 초기 체질량지수(BMI)가 x kg/m2 이상인 비만 환자, 또는
- 한 가지 이상의 체중 관련 동반질환 [예, 이상혈당증 (당뇨병 전단계(pre-diabetes) 또는 제 2형 당뇨병), 고혈압 또는 이상지질혈증]이 있으면서 초기 체질량지수(BMI)가 x kg/m2 이상 x kg/m2 미만인 과체중 환자
x mg/day 용량으로 x주간 투여한 후 초기 체중의 x% 이상이 감량되지 않은 경우에는, 이 약 치료를 중단하여야 한다.
Translation - English This drug is administered as an adjuvant for calorie reduced diet therapy and increased physical activities of adult patients specified as follows.
- Obese patients with an initial body mass index (BMI) of x kg/m^2 or higher, or
- Overweight patients who have one or more weight-related comorbidities [e.g. dysglycemia (a pre-diabetic stage (pre-diabetes) or type 2 diabetes), high blood pressure, or dyslipidemia] along with an initial body mass index (BMI) of x kg/m^2 or higher to less than x kg/m^2
If x% or more of the initial weight is not reduced after x weeks of administration with a dose of x mg/day, treatment with this drug shall be discontinued.
More
Less
Experience
Years of experience: 3. Registered at ProZ.com: Jan 2021. Became a member: Jun 2021.